CAS 1346753-00-1

YHO-13351

CAS : 1346753-00-1

YHO-13351

Degré de pureté : ≥95%

Masse moléculaire : 579.73g/mol

Ref: 54-BUP01418

YHO-13351

CAS : 1346753-00-1

YHO-13351 is an ABCG2 inhibitor that induces sensitization of cancer stem cells/initiating-like side population cells to irinotecan.

Formule : C₂₇H₃₇N₃O₇S₂

Degré de pureté : 97.88%

Couleur et forme : Solid

Masse moléculaire : 579.73

Ref: TM-T13366

YHO-13351

CAS : 1346753-00-1

YHO-13351 is an investigational pharmaceutical compound classified as a small molecule inhibitor. It is synthesized through a series of complex chemical processes involving precise modifications and optimizations to achieve high specificity and potency. This compound operates by selectively inhibiting certain molecular pathways that are implicated in pathological conditions, particularly those involving aberrant cellular proliferation and survival mechanisms.

Formule : C₂₇H₃₇N₃O₇S₂

Degré de pureté : Min. 95%

Masse moléculaire : 579.73 g/mol

Ref: 3D-WDC75300